Printer Friendly

Vascular Solutions Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into Allegations of Corporate Wrongdoing.

NEW YORK, Nov. 19, 2014 /PRNewswire/ -- Securities lawyers at Dunnam & Dunnam are investigating allegations for Vascular Solutions Inc. shareholders (NASDAQ:VASC). Concerned VASC investors who purchased between June 28, 2011 and November 13, 2014 are encouraged to contact securities attorney Hamilton Lindley by clicking here.

The law firm's investigation will focus on the fact that an indictment has been brought against Vascular Solutions Inc. The indictment alleges that Vascular Solutions and its CEO introduced adulterated and misbranded medical devices into interstate commerce, and conspired to introduce adulterated and misbranded medical devices into interstate commerce. When news of the indictment broke, Vascular Solutions' stock fell 11%.

Dunnam & Dunnam has significant experience representing shareholders in securities lawsuits nationwide. VASC stockholders C or anyone with knowledge about this situation C should contact lawyer Hamilton Lindley at with questions or concerns toll free at 844-702-2990 or visit

SOURCE Dunnam & Dunnam

COPYRIGHT 2014 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 19, 2014
Previous Article:New Data From Evolve Clinical Program Demonstrate SYNERGY(TM) Bioabsobable Polymer Stent Meets Key Performance Endpoints.
Next Article:New Hondas available in Allentown, PA.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters